论文部分内容阅读
摘要目的评估~(18)F-FDG PET/CT对小细胞肺癌(SCLC)临床分期的价值,评估以代谢变量[最大标准摄入值(SUV_(max))、代谢肿瘤体积(MTV)和总病变糖酵解(TLG)]和形
Abstract Objective To assess the value of ~ (18) F-FDG PET / CT in the clinical staging of small cell lung cancer (SCLC). Assess the value of metabolic variables [maximum standard intake value (SUV max), metabolic tumor volume Lesion Glycolytic (TLG)] and Morphology